Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide
Carlos Alatorre; Laura Fernández Landó; Maria Yu; Katelyn Brown; Leslie Montejano; Paul Juneau; Reema Mody; Ralph Swindle
Author Information: Eli Lilly and Company, Lilly Corporate Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.